Ratings for Vertex (NASDAQ: VERX) were provided by 7 analysts in the past three months, showcasing a mix of bullish and ...
An analyst known for making timely crypto calls believes that one energy-related stock is on the verge of making a sudden ...
Jupiter Endovascular announced today that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular ...
The FDA granted breakthrough therapy designation to a Vertex Pharmaceuticals kidney disease drug.
Zacks Investment Research on MSN
Vertex (VRTX) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a ...
Scientists have shown that two previously separate modes of plant branching regulation can be connected, revealing the most ...
StockStory.org on MSN
Unpacking Q2 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) In The Context Of Other Therapeutics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q2, starting with Vertex ...
Research led by a physicist at the University of California, Riverside, shows how viruses form protective shells (capsids) ...
TOLEDO, Ohio (WTVG) - Dravet Syndrome is a rare and severe form of epilepsy. Treatment options are limited and a local family is working to help change that. The family is hosting an event later this ...
Rory McIlroy looks to help Team Europe to Ryder Cup victory at Bethpage Black from September 26-28, live on Sky Sports; McIlroy won the Amgen Irish Open in a play-off to claim fourth worldwide victory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results